Aerovate Therapeutics, Inc. (AVTE)
Company Info
| ISIN | US0080641071 |
|---|---|
| CUSIP | 008064107 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $823.91M |
|---|---|
| EPS | -$2.87 |
| EBITDA (TTM) | -$81.31M |
| Year Range | $9.41 - $29.99 |
| Target Price | $45.83 |
| Short % | 5.74% |
| Short Ratio | 8.35 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Aerovate Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Aerovate Therapeutics, Inc. had a return of -4.55% year-to-date (YTD) and 18.94% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -4.55% | 5.06% |
| 1 month | -16.02% | -3.23% |
| 6 months | 89.97% | 17.14% |
| 1 year | 18.94% | 20.62% |
| 5 years (annualized) | N/A | 11.54% |
| 10 years (annualized) | N/A | 10.37% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -14.67% | 19.52% | 28.12% | |||||||||
| 2023 | -14.60% | -21.81% | 48.07% | 44.05% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Aerovate Therapeutics, Inc.(AVTE)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Aerovate Therapeutics, Inc. (AVTE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Aerovate Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aerovate Therapeutics, Inc. was 68.61%, occurring on Oct 27, 2023. Recovery took 105 trading sessions.
The current Aerovate Therapeutics, Inc. drawdown is 29.76%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.61% | Dec 13, 2022 | 220 | Oct 27, 2023 | 105 | Apr 1, 2024 | 325 |
| -63.86% | Jul 1, 2021 | 142 | Jan 21, 2022 | 131 | Aug 1, 2022 | 273 |
| -42.73% | Aug 15, 2022 | 29 | Sep 23, 2022 | 55 | Dec 12, 2022 | 84 |
| -29.76% | Apr 2, 2024 | 13 | Apr 18, 2024 | — | — | — |
| -4.56% | Aug 8, 2022 | 4 | Aug 11, 2022 | 1 | Aug 12, 2022 | 5 |
Volatility
Volatility Chart
The current Aerovate Therapeutics, Inc. volatility is 25.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |